Guest guest Posted March 13, 2007 Report Share Posted March 13, 2007 News headlines from the Fourteenth Conference on Retroviruses and Opportunistic Infections (CROI), Los Angeles Extensive coverage of the major scientific meeting of 2007 from aidsmap.com To view all news reports published, visit: http://www.aidsmap.com/cms1174967.asp CROI: Is there a ceiling to CD4 recovery on virologically effective therapy?Read More >> CROI: Is tenofovir causing kidney problems?Read More >> CROI: Treatment changes and breaks occur at high rate in Ugandan HIV patientsRead More >> CROI: Remission of Kaposi's sarcoma seen in rural Uganda when HIV treatment givenRead More >> CROI: High dietary fat and cholesterol contribute to serum lipid levels in people with HIVRead More >> CROI: High rate of virologic failure on once-daily combination of 3TC, tenofovir and nevirapineRead More >> CROI: Sexually transmitted infections significantly increase risk of drug-resistant HIV transmission Read More >> CROI: Use of both cotrimoxazole and insecticide-treated bednets dramatically lowers the risk of malaria in HIV-positive children Read More >> CROI: Therapeutic concentrations of efavirenz, Kaletra, could be difficult to achieve in some children, with or without rifampicinRead More >> CROI: Large Zambian study finds early abrupt weaning of HIV-exposed infants does not improve HIV-free survival Read More >> CROI: Experimental 'salvage' integrase inhibitor, elvitegravir (GS-9137) appears potent at higher dosesRead More >> CROI: Four African studies suggest health risks associated with abrupt and early weaning of HIV-exposed infants Read More >> CROI: Aciclovir therapy for women with HIV and herpes produces modest reductions in genital viral loadRead More >> CROI: SMART substudy finds people on treatment less likely to transmit HIV, and may take fewer risksRead More >> CROI: Smoking increases cancer-associated HPV viral loadRead More >> CROI: Circumcision could particularly benefit higher-risk menRead More >> CROI: HIV testing in New York's bath houses is feasible and reaches men missed by traditional preventionRead More >> CROI: New NNRTI, TMC278, demonstrates sustained potency, better CNS and lipid profile than efavirenz, in treatment-naiveRead More >> CROI: Early weaning and formula feeding puts HIV-exposed infants in resource limited settings at high risk of severe diarrhoea and deathRead More >> CROI: Rate of CD4 decline is a poor guide to the risk of AIDS, say investigatorsRead More >> CROI: Once daily Kaletra may be less effective when viral load above 100,000 copies/mlRead More >> CROI: Recent OIs or AIDS strongest predictors of development of resistance in South African first-line failuresRead More >> CROI: Haiti is the source of HIV subtype B Read More >> CROI: Anti-HBV drug entecavir also active against HIV and promotes antiretroviral resistanceRead More >> CROI: Further evidence that short-course PMTCT prophylaxis compromises mother's future treatmentRead More >> CROI: Sexual transmission of HCV not limited to HIV-positive gay menRead More >> CROI: Ugandan study confirms low CD4 count, low body weight, TB and anaemia major risk factors for death after starting ARTRead More >> CROI: Effects of transmitted drug resistance on viral load are drug class specificRead More >> CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeksRead More >> CROI: Maraviroc shows potent effect in highly treatment-experiencedRead More >> CROI: Non-AIDS malignancies now more common than AIDS-defining cancers in people with HIVRead More >> CROI: HIV treatment should not be delayed in TB patients with low CD4 counts, South African study showsRead More >> CROI: Cotrimoxazole prophylaxis reduces risk of death by 41% during first six months of ARTRead More >> CROI: Microbicide failure poses more questions than answersRead More >> CROI: Kaletra less likely to cause fat loss than efavirenz when paired with NRTIsRead More >> CROI: Women infected with HIV subtype D progress faster despite same viral loadRead More >> CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes lateRead More >> CROI: Alendronate effectively treats bone loss in men and women with HIVRead More >> CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophyRead More >> CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular diseaseRead More >> CROI: Tenofovir microbicide stops rectal infection in monkeys better than PrEPRead More >> CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern AfricaRead More >> CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapyRead More >> CROI: Urgent action needed to avert `catastrophic` drug-resistant TB epidemicRead More >> Regards, Vergelpowerusa dot orgAOL now offers free email to everyone. Find out more about what's free from AOL at AOL.com. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.